TOKYO -- Takeda Pharmaceutical and two Japanese universities are developing a drug to treat the clogging and inflammation of blood vessels, complications of COVID-19.
Pharmaceuticals
Takeda works on drug to treat COVID complications
Universities collaborate on medicine that might prevent blood vessel inflammation
Researchers at Takeda Pharmaceutical and two Japanese universities hope to bring their drug to market in a few years.
Read Next
.png?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=394)
Latest on Pharmaceuticals
